SILEXION THERAPEUTICS CORP

Historical 13F Holders

Symbol
SLXN
CUSIP
G1281K122
All holders as of
Q2 2025
Type
Equity
Class
SHS NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for G1281K122 since 12/18/2024, largest first.

Filer % of Class Filed
Lincoln Alternative Strategies LLC 13G 6.2% 9/15/2025
Event 9/12/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Intracoastal Capital LLC 13G
4.99% 1/21/2025
Event 1/15/2025
Lind Global Fund III LP 13G/A
4.96% 5/15/2026
Event 3/31/2026
CVI Investments, Inc. 13G/A
4.9% 5/12/2025
Event 3/31/2025
Goldman Sachs Group Inc 13G/A
2.4% 5/13/2025
Event 3/31/2025
Wildcat Capital Management, LLC 13D/A
1.3% 6/26/2025
Event 6/26/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q2 7 282 k $229k
2025 Q1 6 236 k $260k
2024 Q4 4 140 k $281k